October 6, 2009 – Boston Scientific Corp. released data during TCT 2009 from the TAXUS ATLAS clinical program, a ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
October 5, 2009 – The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has ...
October 05, 2009
October 2, 2009 – Results from a multicenter study of Cheetah Medical's Exercise Cardiac Output (ECO) stress test ...
October 02, 2009
October 1, 2009 – Flexible Stenting Solutions Inc. (FSS) said this week it received conditional investigational ...
October 01, 2009October 1, 2009 – Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the ...
October 01, 2009
October 1, 2009 – The six-month clinical outcome of Sahajanand Medical Technologies Supralimus Sirolimus-Eluting ...
October 01, 2009
September 30, 2009 – PLC Systems Inc. demonstrated its RenalGuard System to help prevent contrast-induced ...
September 30, 2009
September 30, 2009 – New clinical data released at TCT 2009 last week showed strong and sustained efficacy and ...
September 30, 2009
September 29, 2009 – Among the biggest news to come out of TCT 2009 last week was the late-breaking data from the ...
September 30, 2009
September 29, 2009 – Abiomed Inc. announced new clinical data last week at TCT 2009 from Academic Medical Center’s ...
September 29, 2009
September 29, 2009 – Mardil Inc. last week at TCT 2009 announced positive interim data from a pilot study ...
September 29, 2009September 29, 2009 – Elixir Medical Corp. last week at TCT 2009 announced positive results from three multicenter ...
September 29, 2009September 29, 2009 – Boston Scientific Corp. Sept. 25 announced two-year follow-up data from the HORIZONS-AMI ...
September 29, 2009
September 29, 2009 – At six months, patients receiving the NEVO Sirolimus-Eluting Coronary Stent reported ...
September 29, 2009September 28, 2009 – New data from the phase III PLATO study showed that ticagrelor (BRILINTA) provided 16 ...
September 29, 2009